These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7158257)

  • 1. [Immunological studies on factor IX antigen in patients with hemophilia B variant].
    Fujimura Y; Takase T; Sakai T; Shima M; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):952-61. PubMed ID: 7158257
    [No Abstract]   [Full Text] [Related]  

  • 2. An immunological method for detection of the carrier of hemophilia B.
    Matsuoka M; Ito M; Takahashi K; Sakuragawa N
    Thromb Haemost; 1976 Nov; 36(2):441-50. PubMed ID: 1036844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of factor IX antigen and coagulant in hemophilia B patients and carriers.
    Pechet L; Tiarks CY; Stevens J; Sudhindra RR; Lipworth L
    Thromb Haemost; 1979 Feb; 40(3):465-77. PubMed ID: 425061
    [No Abstract]   [Full Text] [Related]  

  • 4. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
    Thompson AR
    J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive solid phase enzyme immunoassay for factor IX antigen and classification of hemophilia B.
    Takamatsu J; Kamiya T; Ogata K; Sugihara T; Koie K; Kato K
    Haemostasis; 1983; 13(1):9-16. PubMed ID: 6341181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The abnormal factor IX of hemophilia B+ variants.
    Bertina RM; Veltkamp JJ
    Thromb Haemost; 1978 Oct; 40(2):335-49. PubMed ID: 734633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Classification of hemophilia B and detection of its carriers].
    Takamatsu J; Kamiya T
    Nihon Ketsueki Gakkai Zasshi; 1982 Sep; 45(5):943-51. PubMed ID: 7158256
    [No Abstract]   [Full Text] [Related]  

  • 8. Further studies on factor IX antigen in hemophilia B.
    Girolami A; Burul A; Cappellato G
    Blut; 1978 Oct; 37(4):215-7. PubMed ID: 81079
    [No Abstract]   [Full Text] [Related]  

  • 9. Factor IX antigen by radioimmunoassay in heterozygotes for hemophilia B.
    Thompson AR
    Thromb Res; 1977 Aug; 11(2):193-203. PubMed ID: 905971
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients with hemophilia B (Christmas disease) who have anti-factor IX: genetic heterogeneity.
    Poon MC
    J Lab Clin Med; 1988 Sep; 112(3):283-4. PubMed ID: 3411190
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic studies of factor IX (Christmas factor). I. Counterimmunoelectrophoresis method for factor IX antigen.
    Yang HC
    Thromb Res; 1978 Jul; 13(1):97-109. PubMed ID: 99838
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological heterogeneity of haemophilia B: a multicentre study of 98 kindreds.
    Parekh VR; Mannucci PM; Ruggeri ZM
    Br J Haematol; 1978 Dec; 40(4):643-55. PubMed ID: 103564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantibodies to factor IX in Haemophilia B characterized by crossed immunoelectrophoresis and enzyme-conjugated antisera to human immunoglobulins.
    Orstavik KH
    Br J Haematol; 1981 May; 48(1):15-23. PubMed ID: 6788066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit polyclonal antibodies against the calcium-dependent conformation of factor IX and their application in solid phase immunoradiometric assays.
    Poort SR; van der Linden IK; Krommenhoek-van Es C; Briët E; Bertina RM
    Thromb Haemost; 1986 Feb; 55(1):122-8. PubMed ID: 3704999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic studies of factor IX (Christmas factor). II. Immunoradiometric assay of factor IX antigen.
    Yang HC
    Br J Haematol; 1978 Jun; 39(2):215-24. PubMed ID: 678474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilia B variants.
    Yoshioka A
    Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1667-77. PubMed ID: 6532052
    [No Abstract]   [Full Text] [Related]  

  • 17. Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.
    Brooks MB; Gu W; Ray K
    J Am Vet Med Assoc; 1997 Dec; 211(11):1418-21. PubMed ID: 9394892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological aspects of some vitamin K-dependent factors and preparation of depleted plasmas.
    Seegers WH; Hassouna HI; Novoa E
    Thromb Res; 1977 Nov; 11(5):633-42. PubMed ID: 929512
    [No Abstract]   [Full Text] [Related]  

  • 19. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
    Schimpf K; Schwarz P; Kunschak M
    Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
    [No Abstract]   [Full Text] [Related]  

  • 20. Electroimmunoassay of factor IX antigen: increased sensitivity by enzyme amplification of immunoprecipitates.
    Orstavik KH
    Thromb Res; 1979; 15(5-6):721-6. PubMed ID: 386558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.